Skip to main content

Ultra Rapid Microbial Detection in Cell and Gene Therapy Products

2023 ISCT Annual Meeting, Paris - 31 May – 3 June 2023

Ultra Rapid Microbial Detection in Cell and Gene Therapy Products

Introduction

The SCANRDI® is an ultra-rapid alternative technology for detecting microbial contaminants in drug products. Designed to meet compendial testing standards, studies on Limit of Detection (LoD) and Equivalency have been performed with a focus on species listed by the Pharmacopeias microorganisms. The Most Probable Number (MPN) was used to demonstrate that the LoD of the SCANRDI® CELL-BURST is not significantly different from the LoD of a traditional plate counting method on 10 compendial strains. To show the equivalency, we compared the proportion of positive results between both methods for all strains and all dilutions with a non-inferiority test of Farrington-Manning, with a 20% margin.

ULTRA-RAPID MICROBIAL DETECTION IN CELL & GENE THERAPY PRODUCTS

Filename
Poster ULTRA-RAPID MICROBIAL DETECTION IN CELL AND GENE THERAPY PRODUCTS - ISCT 2023.pdf
Size
460 KB
Format
application/pdf
Fully Automated PCR-based Detection

Product

Ultra-Rapid Microbial Detection in Cell and Gene Therapy Products

The SCANRDI® is an ultra-rapid alternative technology for detecting microbial contaminants in drug products.

bioMérieux ensures the safety of patients undergoing cell and gene therapies

Expert Interview

How bioMérieux ensures the safety of patients undergoing cell and gene therapies

With a complete portfolio of Quality Control solutions, bioMérieux ensures the safety of patients undergoing cell and gene therapies. - Felix A. Montero Julian, PhD Scientific Director Pharma Quality Control